ANGLE provides comprehensive and customised liquid biopsy biomarker analysis services with a mission to advance the development of new cancer therapies and personalised medicine. Our innovative circulating tumour cell (CTC) biomarker assays and single blood tube dual analysis (CTC-DNA and cfDNA) are highly sensitive, specific and repeatable, making them reliable tools for research and drug development.
Leveraging ANGLE’s precision oncology programme and incorporating circulating tumour cell (CTC) analysis or ANGLE’s proprietary single blood tube dual analysis (CTC-DNA and cfDNA) into your clinical biomarker strategy could offer new insights to assist in target validation and patient selection. Our GCP-compliant service and R&D laboratories provide biomarker screening services and can develop specific biomarker assays tailored to your needs. We empower researchers and biopharma partners with robust, validated liquid biopsy solutions for biomarker discovery, companion diagnostics, and treatment response monitoring. Our patented Parsortix® technology delivers unmatched purity of CTCs, enabling a wide range of downstream analyses including genomics, proteomics, and single-cell applications.
Join us at the 15th World Clinical Biomarkers & Companion Diagnostics Summit to explore how ANGLE is redefining biomarker discovery and driving forward the next generation of precision diagnostics.
Secure your 1:1 appointment below and learn more about:
Location
Boston, MA, USA
Date
September 22 - 25, 2025
Request a meeting with the ANGLE team at the 15th World CB & CDx Summit
Brett Swansiger
Chief Commercial Officer
Brett plays a key role in our global corporate partnerships and overseeing our commercial teams in their biopharma services activities and research/clinical product solutions. Brett has over 20 years of commercial leadership, international business development, and business to business sales.
Mark Rogers
Senior US Biopharma Partnering Lead
Working within ANGLE’s Biopharma Services team, Mark is focused on the United States and Canada. With over 20 years of experience in life sciences and clinical diagnostics, his expertise includes strategic pharmaceutical partnerships, diagnostic development, and clinical genomics.
Brett Swansiger
Chief Commercial Officer
Brett plays a key role in our global corporate partnerships and overseeing our commercial teams in their biopharma services activities and research/clinical product solutions. Brett has over 20 years of commercial leadership, international business development, and business to business sales.
Mark Rogers
Senior US Biopharma Partnering Lead
Working within ANGLE’s Biopharma Services team, Mark is focused on the United States and Canada. With over 20 years of experience in life sciences and clinical diagnostics, his expertise includes strategic pharmaceutical partnerships, diagnostic development, and clinical genomics.